POP Biotechnologies (POP BIO), a UB spinout headquartered in BEP’s Incubator @ Baird, has developed a novel vaccine adjuvant used to make vaccines and drug treatments more effective. With support from BEP, the company has doubled its staff and secured more than $10 million in funding.